Search
Search results
59 results found
Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer.
Iesato, Asumi, and Carmelo Nucera. 2021. “Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer.”. Advances in Experimental Medicine and Biology 1329: 253-69.
Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAFV600E Papillary Thyroid Carcinoma.
Valvo, Veronica, Asumi Iesato, Taylor R Kavanagh, Carmen Priolo, Zsuzsanna Zsengeller, Alfredo Pontecorvi, Isaac E Stillman, Suzanne D Burke, Xiaowen Liu, and Carmelo Nucera. 2021. “Fine-Tuning Lipid Metabolism by Targeting Mitochondria-Associated Acetyl-CoA-Carboxylase 2 in BRAFV600E Papillary Thyroid Carcinoma.”. Thyroid : Official Journal of the American Thyroid Association 31 (9): 1335-58.
A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer.
Nucera, Carmelo. 2019. “A Novel Combined Targeted Therapy With Bromodomain Antagonist and MEK Inhibitor in Anaplastic Thyroid Cancer.”. Oncotarget 10 (7): 686-87.
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E.
Antonello, Zeus A, Nancy Hsu, Manoj Bhasin, Giovanni Roti, Mukta Joshi, Paul Van Hummelen, Emily Ye, et al. 2017. “Vemurafenib-Resistance via de Novo RBM Genes Mutations and Chromosome 5 Aberrations Is Overcome by Combined Therapy With Palbociclib in Thyroid Carcinoma With BRAFV600E.”. Oncotarget 8 (49): 84743-60.
Invasive follicular variant of papillary thyroid cancer harboring the NRAS mutation Q61K and presenting with bone metastasis-A case report.
Mehrzad, Raman, Michiya Nishino, Carmelo Nucera, Dora Dias-Santagata, James Hennessey V, and Per-Olof Hasselgren. 2017. “Invasive Follicular Variant of Papillary Thyroid Cancer Harboring the NRAS Mutation Q61K and Presenting With Bone Metastasis-A Case Report.”. International Journal of Surgery Case Reports 38: 180-84.
Effect of the micronutrient iodine in thyroid carcinoma angiogenesis.
Daniell, Kayla, and Carmelo Nucera. 2016. “Effect of the Micronutrient Iodine in Thyroid Carcinoma Angiogenesis.”. Aging 8 (12): 3180-84.
Evolution of resistance to thyroid cancer therapy.
Nucera, Carmelo. 2016. “Evolution of Resistance to Thyroid Cancer Therapy.”. Aging 8 (8): 1576-7.
Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.
Sadow, Peter M, Dora Dias-Santagata, Zongli Zheng, Derrick T Lin, Long Phi Le, and Carmelo Nucera. 2015. “Identification of Insertions in PTEN and TP53 in Anaplastic Thyroid Carcinoma With Angiogenic Brain Metastasis.”. Endocrine-Related Cancer 22 (6): L23-8.
Genomic and immunohistochemical analysis in human adrenal cortical neoplasia reveal beta-catenin mutations as potential prognostic biomarker.
Kovach, Alexandra E, Carmelo Nucera, Quynh T Lam, Ahnthu Nguyen, Dora Dias-Santagata, and Peter M Sadow. 2015. “Genomic and Immunohistochemical Analysis in Human Adrenal Cortical Neoplasia Reveal Beta-Catenin Mutations As Potential Prognostic Biomarker.”. Discoveries (Craiova, Romania) 3 (2).